(Q33910801)

30 July 2017

title

Kala-azar--new developments in diagnosis and treatment (English)

1 reference

30 July 2017

main subject

visceral leishmaniasis

1 reference

Aggarwal P

1

1 reference

30 July 2017

Handa R

series ordinal

2

1 reference

30 July 2017

Singh S

series ordinal

3

1 reference

30 July 2017

Wali JP

series ordinal

4

1 reference

30 July 2017

publication date

1 January 1999

1 reference

Indian Journal of Pediatrics

30 July 2017

published in

1 reference

30 July 2017

volume

66

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

63-71

1 reference

Profile of kala-azar in north India.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02752355

Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02752355

Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02752355

Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02752355

Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial

21 January 2018

1 reference

12 December 2020

Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kala-azar--a comparative study

1 reference

12 December 2020

Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.

1 reference

12 December 2020

Enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Bhadohi (Varanasi), India

1 reference

12 December 2020

Serological diagnosis of visceral leishmaniasis by a dot-enzyme immunoassay for the detection of a Leishmania donovani-related circulating antigen

1 reference

12 December 2020

Anti-66 kDa antileishmanial antibodies as specific immunodiagnostic probe for visceral leishmaniasis

1 reference

12 December 2020

Recommendations for Treating Leishmaniasis with Sodium Stibogluconate (Pentostam) and Review of Pertinent Clinical Studies

1 reference

12 December 2020

Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study

1 reference

12 December 2020

Standardization of the dot enzyme-linked immunosorbent assay (Dot-ELISA) for human visceral leishmaniasis

1 reference

12 December 2020

Direct agglutination test for early diagnosis of Indian visceral leishmaniasis.

1 reference

12 December 2020

Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of visceral Leishmaniasis in immunocompromised patients

1 reference

12 December 2020

Rapid diagnosis of Indian visceral leishmaniasis using achatininH, a 9-O-acetylated sialic acid binding lectin

1 reference

12 December 2020

Comparative evaluation of serological tests in Indian kala-azar

1 reference

12 December 2020

Improvement of a direct agglutination test for field studies of visceral leishmaniasis

1 reference

12 December 2020

Ketoconazole in treatment of visceral leishmaniasis

1 reference

12 December 2020

A direct agglutination test for leishmaniasis

1 reference

12 December 2020

Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India

1 reference

12 December 2020

Short report: detection of 72-75-kD and 123-kD fractions of Leishmania antigen in urine of patients with visceral leishmaniasis

1 reference

12 December 2020

A sensitive ELISA for detection of circulating antigens in kala azar patients

1 reference

12 December 2020

Comparative evaluation of serological tests for diagnosis of visceral leishmaniasis

1 reference

12 December 2020

Liposomal amphotericin B in drug-resistant visceral leishmaniasis

1 reference

12 December 2020

Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02752355

1 reference

Dimensions Publication ID

30 July 2017

1014373907

0 references

1 reference